Share This

Related Topics News -

     
 Detail   |   Print 
     
《大行》建銀國際降阿里健康目標價至4.2元 評級「跑贏大市」
2024-04-11T  
《大行報告》大華繼顯降阿里健康目標價至4元 下調今明兩年收入預測
2024-04-05T  
《大行報告》里昂降阿里健康目標價至4.1元 料下半年比預期嚴峻
2024-04-03T  
《大行報告》匯豐研究降阿里健康目標價至4.5元 線上藥物銷售前景面臨挑戰
2024-04-03T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.